M
any microbial pathogens have evolved mechanisms to inhibit innate immune signaling pathways, thereby limiting the ability of infected cells to propagate inflammatory cues such as cytokine secretion (1, 2) . Of the signaling pathways frequently targeted by pathogens, NF-kB and MAPK pathways elicit key host-protective antimicrobial defenses (3) . However, these signaling pathways are also coupled to prosurvival signals that limit cell death pathways activated by microbial pattern recognition and cytokine receptors (3) . Inhibition of innate immune signaling can, therefore, not only result in a block in cytokine and antimicrobial effector production but also trigger cell death. This induction of cell death may be an evolutionarily ancient response to pathogen virulence factors.
The YopJ protein of pathogenic yersiniae is an acyl-transferase that belongs to a family of secreted virulence factors injected into host cells by bacterial pathogens that infect plants, insects, and higher eukaryotes (4) (5) (6) . The activity of YopJ blocks MAPK and NF-kB signaling to interfere with the production of inflammatory cytokines (7) (8) (9) . In the absence of YopJ, the virulence of Yersinia pseudotuberculosis is attenuated in vivo following oral infection (10) . However, in addition to inhibiting cytokine production, YopJinduced blockade of NF-kB and MAPK signaling also triggers cell death downstream of TLR4-dependent TRIF signaling (7, (11) (12) (13) (14) (15) (16) .
TLR4/TRIF-dependent cell death induced by YopJ requires the components of the extrinsic apoptosis pathway, specifically RIPK1, Fas-associated death domain (FADD), and caspase-8 (17) (18) (19) . Interestingly, although absence of RIPK1 or caspase-8 abrogates YopJ-induced cell death, TLR4-and TRIF-deficient cells still exhibit significant, although reduced, death (13-15, 18, 19) , implying that an additional TLR4/TRIF-independent signal contributes to Yersinia-induced apoptosis. However, such a pathway has not previously been described.
The TNFR superfamily comprises a number of cell surface receptors that are coupled to induction of both transcriptional and apoptotic responses (20) . Notably, TNFR1 can induce extrinsic apoptosis through RIPK1 and caspase-8 in a variety of immune and parenchymal tissues (21) . This response can have protective roles in the context of tumorigenesis but is pathologic in the setting of liver and intestinal damage (21, 22) . In the context of infection, however, TNF is thought to act primarily as a mediator of inflammation and activator of innate immune and endothelial cells. YopJ blockade of NF-kB and MAPK activation virtually eliminates the production of TNF and other inflammatory cytokines by Yersinia-infected cells (7) (8) (9) . Thus, the potential contribution of TNF signaling to Yersiniainduced cell death has never been examined.
In this article, we identify a key role for TNF in promoting Y. pseudotuberculosis-induced cell death and demonstrate that despite the greatly reduced TNF production that accompanies infection with virulent Y. pseudotuberculosis, TNF/TNFR1 is responsible for TRIF-independent apoptosis of infected cells. Intriguingly, cells undergoing apoptosis and cells producing TNF represented distinct populations. Unexpectedly, TNF-producing cells were injected with Yersinia YopJ, although to a significantly lower level than apoptotic cells. Thus, in a phenotypically heterogeneous population of infected cells, TNF production by cells that are injected but remain uninhibited by YopJ synergized with TRIF to promote maximal apoptosis in response to Yersinia infection. Finally, oral infection of TNFR1-deficient mice demonstrated a protective function for TNFR1 signaling in vivo. These findings establish an unanticipated role for cytokine responses in directing apoptosis of Yersinia-infected cells and a potential role for TNFR1-dependent apoptosis in promoting host protection against Yersinia infection.
Materials and Methods

Cell culture and infections
Bone marrow-derived macrophages (BMDMs) from C57BL/6J (Jackson), Tnfrsf1a 2/2 (23) (Jackson), Trif 2/2 (24), and Trif 2/2 Tnfr1 2/2 mice (25) were cultured and infected as previously described (19) . Y. pseudotuberculosis strain IP2666 and isogenic yopJ mutant bacteria were grown overnight with aeration in 23YT broth at 26˚C. Y. pseudotuberculosis were diluted into inducing media (23YT containing 20 mM sodium oxalate and 20 mM MgCl 2 ) and grown with aeration for 1 h at 26˚C followed by 2 h at 37˚C. BMDMs were infected at a multiplicity of infection (MOI) of 20:1, unless otherwise noted. Cells were incubated at 37˚C, and gentamicin (100 mg/ ml) was added 1 h post infection. The following were added 1 h before infection, where indicated: 100 mM zVAD-fmk (zVAD; SM Biochemicals), 60 mM necrostatin-1 (Nec-1; Calbiochem), 3 mM GSK2399872A (GSK'872; GlaxoSmithKline), 50 mM TAPI-2 (SigmaAldrich), and 80 mM dynasore (Sigma-Aldrich).
Cell death
Lactate dehydrogenase (LDH) release was measured from cell supernatants and quantified using the Cytotox96 Assay Kit (Promega) according to the manufacturer's instructions and as previously described (19) . For flow cytometry, cells were stained with the Zombie Yellow Fixable Viability Kit (BioLegend) and with CD45.2 and CD45.1 Abs (BioLegend) prior to fixation and permeabilization (BD Cytofix/Cytoperm Kit). Cells were stained for intracellular TNF (BioLegend) and cleaved caspase-3 (#9661; Cell Signaling). Flow cytometry samples were analyzed on the LSR II or LSRFortessa (BD).
Western blotting and ELISA
Cell lysates were harvested in lysis/sample buffer and run on 4-12% NuPAGE gels (Invitrogen). Proteins were transferred to a polyvinylidene difluoride membrane (Millipore) and blotted for caspase-8 (1G12; Enzo Life Sciences), caspase-3 (#9662; Cell Signaling), caspase-1 (sc-514; Santa Cruz), and b-actin (Sigma-Aldrich). Cytokine release was measured by ELISA on cell supernatants, using capture and detection Abs against TNF (430902; BioLegend) and CCL5 (500-P118 and 500-P118Bt; PeproTech).
CCF4-AM injection assay
BMDMs were infected with YopJ-deficient bacteria complemented with b-lactamase-linked YopJ or GST control expressing plasmid (pACYC). At 1 h post infection, cells were loaded with CCF4-AM (LiveBLAzer FRET-B/G Loading Kit; Invitrogen) according to the manufacturer's instructions, including the addition of probenecid and with the modification of diluting Solution C 4-fold in HBSS. Cells were returned to 37˚C and harvested for cell staining as above for TNF and cleaved caspase-3 at 2 h post infection.
Animal infections
Mice were fasted for 12-16 h and inoculated by gastric gavage with 2 3 10 8 CFU wild-type (Wt) Y. pseudotuberculosis (32777) from overnight culture in 23YT containing irgasan. Tissues were collected, bead homogenized (MP Biomedical), and plated at 10-fold dilutions on LB plates containing irgasan to determine bacterial burdens (CFU per gram tissue). All animal studies were performed in accordance with University of Pennsylvania Institutional Animal Care and Use Committee approved protocols.
Video microscopy
Immortalized B6 macrophages were plated on 35-mm polymer coverslip dishes (Ibidi) 16 h prior to infection. Propidium iodide (PI) (Calbiochem) was added to the media and cells were infected with Yersinia as described above. Gentamicin was added 1 h post infection at the microscope. Cells were imaged on a Yokagawa spinning disk confocal microscope at 363 magnification, 37˚C and 5% CO 2 over 4 h.
Results
Yersinia YopJ promotes TRIF-dependent and -independent apoptosis through RIPK1 kinase activity YopJ promotes caspase-8-dependent apoptosis of innate immune cells through the inhibition of NF-kB-and MAPK-dependent prosurvival signaling (7, 12, (16) (17) (18) (19) . Although this response has been attributed to TLR4/TRIF (13) (14) (15) , TRIF-deficient BMDMs still undergo significant Yersinia-induced death (14, 15, 18, 19) . This finding implies a role for additional pathways in the induction of cell death. Both TRIF and death receptor signaling can promote survival, caspase-8-dependent apoptosis, or RIPK3-dependent programmed necrosis, depending on the nature of the genetic and environmental conditions present (26) . We therefore sought to determine whether TRIF-independent death is also mediated by caspase- 1B) . Importantly, single deficiency of RIPK3 (18, 19) or GSK'872 treatment alone (Fig. 1B ) has no effect on Yersinia-induced cell death of BMDMs. These data indicated that Y. pseudotuberculosisinduced cell death in both Wt and Trif 2/2 BMDMs is mediated by caspase-8-dependent apoptosis and is independent of RIPK3-programmed necrosis. Whereas YopJ-induced apoptosis in Wt BMDMs requires the signaling molecule RIPK1 (18, 19) , caspase-8 can mediate apoptosis via RIPK1 kinase-dependent or -independent pathways (22) . Whether TRIF-independent cell death depends on RIPK1 activity is unknown. Importantly, Nec-1, a specific inhibitor of RIPK1 kinase activity, reduced YopJ-induced apoptosis of both Wt and Trif 2/2 BMDMs (Fig. 1C) . Altogether, these data demonstrate that both the TRIF-dependent cell death and TRIF-independent cell death induced by Y. pseudotuberculosis involve RIPK1 kinasedependent apoptosis.
TNFR1 mediates TRIF-independent apoptosis and caspase-1 cleavage during Yersinia infection
The TNFR superfamily mediates extrinsic apoptosis through recruitment and activation of FADD, RIPK1, and caspase-8 (21, 22) . Given the requirement for all three of these factors in Yersiniainduced apoptosis (17) (18) (19) , we therefore tested the possibility that TNF might play a role in Y. pseudotuberculosis-induced cell death. Surprisingly, despite the known blockade of TNF production by YopJ (7-9), TNFR1-deficient (Tnfr1
) BMDMs displayed significantly decreased cell death and caspase-3 cleavage, compared with Wt BMDMs (Fig. 2A, Supplemental Fig. 2A ). Strikingly, macrophages deficient for both TRIF and TNFR1 (Trif In addition to the activation of apoptotic caspases, Yersinia infection of unprimed BMDMs induces caspase-1 activation through a RIPK1, caspase-8, and FADD pathway (18, 19, 27, 28) . This pathway of inflammasome-independent caspase-1 activation occurs downstream of TLR4/TRIF signaling during Yersinia infection (18, 19 100 mM zVAD-fmk (zVAD), 300 nM GSK'872, and 60 mM Nec-1. Error bars indicate mean 6 SD of triplicates and are representative of three or more independent experiments. ND, not detected. Interestingly, although most BMDMs infected with Yersinia exhibited a profound blebbing of cellular membranes prior to taking up the membrane-impermeant dye PI, indicative of apoptosis (Supplemental Video 1), some cells appeared to lyse and release their cytoplasm concomitant with becoming PI positive, suggestive of pyroptosis or programmed necrosis-like morphology and kinetics (Supplemental Video 2). This observation is consistent with our previous findings that caspase-1 contributes to Yersiniainduced cell death, but is not absolutely required (19) , suggesting that at least some fraction of the cells undergo pyroptosis in response to Y. pseudotuberculosis infection. Overall, these findings provide the first direct evidence, to our knowledge, that TNF/ TNFR1 signaling contributes to Yersinia-induced cell death and caspase-1 processing.
Cell-extrinsic TNF promotes Yersinia-induced apoptosis
Given the well-established impact of YopJ on limiting NF-kB and MAPK signaling, which blocks production of cytokines, including TNF (7-9), we sought to determine the source of the TNF that was responsible for the Y. pseudotuberculosis-induced cell death. As expected, Y. pseudotuberculosis-infected cells secreted very low but detectable amounts of TNF compared with BMDMs infected with YopJ-deficient bacteria (Fig. 3A) . Trif 2/2 cells secreted even less TNF compared with Wt cells (Fig. 3A) . Single-cell analysis of TNF expression by flow cytometry demonstrated that, indeed, the vast majority of Y. pseudotuberculosis-infected cells produced little to no TNF and overlapped with uninfected cells; however, we observed a small but significant population of Y. pseudotuberculosisinfected cells that produced low levels of TNF in response to Y. pseudotuberculosis infection (Fig. 3B) . Intriguingly, this TNF-producing population was entirely distinct from the cells undergoing apoptosis, as determined by cleaved caspase-3 staining (Fig. 3C ). These data imply that a subset of cells within Y. pseudotuberculosis-infected cultures serves as the source of TNF that promotes YopJ-induced cell death in nonproducing cells. TNF could be absent in the cleaved caspase-3-positive cells because they are dying or have already released TNF owing to loss of membrane integrity at the time of the analysis. This explanation is unlikely, however, as the cells were gated on live cells that had an intact plasma membrane. Importantly, Tnfr1 2/2 cells exhibited no difference in their ability to produce TNF but had greatly reduced levels of cleaved caspase-3, demonstrating a key role for TNFR signaling in promoting Y. pseudotuberculosis-induced apoptosis (Fig. 3C ).
Heterogeneous injection of YopJ leads to TNF production by a subset of infected cells
The blockade of inflammatory innate signaling and cytokine production by YopJ limits, but does not completely abrogate, production of TNF by infected cells. These TNF producers could be uninfected cells, cells that escaped injection of YopJ, or cells that are somehow resistant to the effects of YopJ. To distinguish between these possibilities, we used a YopJ-b-lactamase (BlaM) injection reporter system (29) to determine whether cells that were injected by YopJ were capable of producing TNF. This reporter system takes advantage of a compound fluorophore, CCF4-AM, which contains a b-lactam ring, and whose fluorescence properties are therefore altered in the presence of b-lactamase (29) . YopJdeficient Y. pseudotuberculosis were complemented with YopJ protein fused to b-lactamase (YopJ-Bla), which reconstituted the ability to inhibit cytokine expression and to induce apoptosis (Supplemental Fig. 3 ). Detection of CCF4-AM cleavage thus provided us with a way to quantitate cells specifically injected with functional YopJ protein because it was fused directly to b-lactamase. Intriguingly, we observed that under these infection conditions, all of the BMDMs in culture were injected by YopJ, but that a subset of the cells exhibited low injection (Fig. 4A) . Importantly, all of these low-injection cells were negative for cleaved caspase-3 ( Fig. 4B ) but made up the entirety of the TNFproducing population of cells (Fig. 4C) . Notably, all of the cells containing cleaved caspase-3 were highly injected, suggesting that apoptosis requires a high level of YopJ injection (Fig. 4B) . Interestingly, lack of TNFR1 did not significantly alter the relative abundance of low-injection versus high-injection cells, but significantly reduced the frequency of cleaved caspase-3-positive cells (Fig. 4B ). This finding suggested that TNFR1 signaling increased the likelihood that a YopJ-injected cell would undergo apoptosis. The preferential production of TNF by low-injection cells could be due to levels of injected YopJ in these cells being below a threshold necessary to efficiently block cell signaling and cytokine production. To test the relationship between infection dose, cell death, and TNF production, we titrated the dose of Y. pseudotuberculosis infection down from 20 to 2.5. As expected, this resulted in a corresponding increase in the frequency of lowinjection cells (Fig. 4D ). There was a corresponding increase in the frequency of TNF-producing cells and a decrease in the frequency of apoptotic cells (Fig. 4D-F) . Thus, although the number of TNF-producing cells rises as the MOI decreases, cell death likely decreases owing to a combination of reduced TLR stimulation at lower MOIs, together with levels of injected YopJ falling below a threshold necessary for the induction of apoptosis. Altogether, these studies demonstrate that heterogeneity in the extent of injection is present within a seemingly uniform population of cells, and that differences in injection efficiency account for the ability of a subset of cells to produce TNF, resulting in enhanced apoptosis of highly injected cells.
Membrane TNF and endocytic trafficking promote TRIF-independent apoptosis during Yersinia infection
TNF secretion is regulated transcriptionally as well as at a posttranslational step, in which trimeric TNF is assembled on the cell surface and subsequently released as a soluble cytokine by the metalloprotease TNF-a-converting enzyme (TACE) (30, 31) . Of interest, both membrane-bound and soluble TNF are able to mediate many of the inflammatory effects of TNF (32) (33) (34) . We therefore used a specific TACE inhibitor to test whether secreted TNF was required or whether membrane-bound TNF was sufficient to promote Y. pseudotuberculosis-induced apoptosis. As expected, TACE inhibitor treatment dramatically reduced the amount of TNF released into the cell supernatant (Fig. 5A) . Surprisingly however, TACE inhibitor treatment had no impact on Y. pseudotuberculosis-induced cell death in Wt or Trif 2/2 cells, suggesting that surface TNF is sufficient to provide proapoptotic signals in the context of YopJ (Fig. 5B) . Although TNFR1-mediated signaling through NF-kB and MAPK pathways is initiated upon receptor ligation at the plasma membrane, internalization is thought to be required for the formation of the death-inducing signaling complex (DISC) that initiates apoptosis (35) (36) (37) . Notably, activation of TRIF-dependent transcriptional responses downstream of TLR4, including the induction of type-I IFN and certain other chemokines such as CCL5, also require TLR4 endocytosis, which is mediated by dynamin (38) . This is in contrast to MyD88-dependent TLR4 signaling, which occurs from the plasma membrane. As expected, blocking dynaminmediated endocytosis potently inhibited the production of the TRIF-dependent cytokine CCL5 by Wt cells (Fig. 5C ). Interestingly, this blocking also completely prevented Y. pseudotuberculosisinduced apoptosis in Wt, TRIF-deficient, and TNFR-deficient BMDMs (Fig. 5D ). These data implicate dynamin-dependent endocytosis in both TNFR1-and TRIF-dependent Y. pseudotuberculosisinduced apoptosis.
Cell-extrinsic soluble or membrane-bound TNF promotes Y. pseudotuberculosis-induced apoptosis
The TACE inhibitor studies indicated that membrane TNF was sufficient to promote Y. pseudotuberculosis-induced cell death, but did not exclude the possibility that soluble TNF mediates this effect under normal circumstances. Indeed, addition of soluble TNF to Tnf 2/2 BMDMs fully restored Y. pseudotuberculosisinduced apoptosis to Wt levels (Fig. 6A, 6B ). The significantly reduced levels of TNF produced by TRIF-deficient cells could potentially also account for the reduced level of apoptosis in these cells. However, although TNF addition slightly increased Y. pseudotuberculosis-induced apoptosis of Trif 2/2 BMDMs, it was not fully restored to Wt levels, demonstrating that TRIF and TNF play distinct, non-redundant roles in mediating Y. pseudotuberculosisinduced death (Fig. 6B) .
To Fig. 4, Fig. 5B ). This finding suggests that when cell-cell contacts are limiting, TNF secreted by Wt cells plays a key role in promoting Y. pseudotuberculosis-induced apoptosis. However, when cell-cell contact between TNF-producing and nonproducing cells is not limiting, cell surface TNF is sufficient to mediate maximal apoptosis. Collectively these studies indicate that both cell surface and soluble TNF are capable of promoting Y. pseudotuberculosis-induced apoptosis and likely have a common function during infection. Finally, we sought to determine whether TNFR1-dependent apoptosis significantly affected control of Y. pseudotuberculosis during in vivo infection. Compared with Wt mice, Tnfr1 2/2 mice had increased bacterial burdens in both the spleen and liver 5 d after oral infection. This indicates an important in vivo role for TNF signaling in host defense that may depend on the induction of TNFR1-dependent apoptosis (Fig. 6D) . Altogether, these results reveal a previously unappreciated role for cell-extrinsic TNF in macrophage killing during Yersinia infection and suggest that this function contributes to antibacterial immune defense.
Discussion
Cell death is a prominent feature of infection by many pathogens, including Yersinia (7, 10, 11). During Yersinia infection, cell death is triggered by the activity of YopJ, which promotes bacterial dissemination from mucosal tissues (10). However, Yersiniainduced cell death may also provide a means for infected cells to elicit inflammatory signals or induce phagocytosis of cellassociated bacteria to overcome YopJ-dependent signaling inhibition (39) (40) (41) . Although TLR4/TRIF contribute to apoptosis during Yersinia infection, significant cell death occurs in Yersinia-infected cells even in the absence of TLR4/TRIF-dependent signals (13) (14) (15) . These data suggest that an additional, as-yet-undefined, pathway contributes to Yersinia-induced cell death. In this article, we show a key role for TNF signaling in promoting Yersinia-induced apoptosis, implicating innate cytokine signaling in promoting host cell death during infection. To our knowledge, this is the first direct evidence that TNF signaling contributes to Yersinia-induced macrophage apoptosis, and supports a model in which cell-extrinsic cytokine signals play an important role in mediating the death of Yersinia-infected cells.
The role of TNF in Yersinia-induced apoptosis may be particularly important because at 37˚C, Yersinia alters its LPS to a form that is poorly detected by TLR4 (42) (43) (44) . This feature likely limits both antibacterial cytokine responses and TLR4-dependent induction of apoptosis in vivo. Thus, additional pathways to promote apoptosis may play critical roles in host defense. Indeed, TRIF deficiency alone does not significantly affect control of Yersinia pseudotuberculosis in an in vivo oral infection model (45) , and Fas/Fas ligand (FasL) contribute to apoptosis of Y. pestis-infected cells in the lung and promote control of infection (46) . Our studies now demonstrate an important role for TNFR1 in control of oral Y. pseudotuberculosis infection, which contrasts both with TRIF deficiency and with previous investigations of the contribution of TNFR1 to control of Yersinia during systemic infection (45, 47) . Prior studies with Y. enterocolitica found that TNFR1 played a pathologic role and that Tnfr1 2/2 mice were more resistant to infection (47) . These differences may be due to either the Yersinia species or the route of infection. Furthermore, although Y. pseudotuberculosis inhibits TNF production by cells that it encounters at sites of infection, the recruitment of additional effector cells offers an abundant source of TNF for inducing apoptosis and potential clearance of cells inhibited during earlier stages of infection. Newly recruited cells would likely not have been exposed to the inhibitory effects of Yersinia-injected virulence factors and may even be primed by inflammatory cues to produce TNF while entering the infected tissue. Notably, primed macrophages and monocytes respond differently when encountering Yersinia than do naive macrophages, particularly with respect to their mode of cell death (48) . Although cytotoxic lymphocytes, including NK cells and adaptive T cells, contribute to the killing of Yersinia-infected cells later in infection (41), our findings suggest that innate immune cells could play an early role in inducing apoptotic cell death through cytokinedependent signaling.
Our data revealed that heterogeneity in the level of injected YopJ and bacterial inhibition of cell signaling results in a subset of cells being able to produce TNF, despite the block in NF-kB signaling imposed by YopJ. Titrating the infection of BMDMs results in both increased TNF production and decreased apoptosis, implying that a high threshold of injected YopJ is needed to prevent cytokine production and to potentiate TNF-induced apoptosis in infected cells. In mixed cultures, only a very small fraction of TNFproducing cells is sufficient to induce maximal cell death of TNFdeficient cells, consistent with the finding that exogenous TNF also restores cell death to Tnf 2/2 cells. Intriguingly, titrating the ratio of TNF-sufficient and TNF-deficient cells while blocking TNF secretion revealed that limiting cell-cell contact between TNF producers and nonproducers increased the importance of secreted TNF in cell death. Thus, our data demonstrate that cell surface TNF is capable of providing the apoptotic signal if secretion is inhibited. Our data also demonstrated a requirement for dynamindependent endocytosis in the induction of both TLR4/TRIF-and TNFR1-induced apoptosis. This requirement is presumably dependent on the formation of an intracellular DISC, raising the question of how extrinsic TNF might mediate its apoptotic effect when membrane bound. TNF that cannot be cleaved from the surface of cells owing to mutation of the TACE cleavage site is also capable of inducing apoptosis in TNFR-expressing cells (33) . Notably, similar findings have been reported for other surface protein members of the TNF family, particularly FasL (49) . FasL is expressed on activated NK cells and CD8 + T cells, and contributes to their ability to induce apoptosis of infected cells (50) (51) (52) . Importantly, membranebound FasL is sufficient to induce Fas internalization, formation of a DISC, and apoptosis (49) . Thus, the requirement for endocytosis may apply only to a receptor signaling complex, independent of death receptor ligand, for the induction of apoptosis.
Whether cell surface TNF is a primary driver of apoptosis when large amounts of TNF are being secreted, and whether it is sufficient to mediate the full extent of protection from bacterial infection in vivo remains to be determined. Overall, our results provide new insight into mechanisms governing pathogen-induced apoptosis, and highlight a previously unappreciated synergy between TLR and TNFR that regulates the response to bacterial infection. 
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